graeme.smethurst@sptlabtech.com
SPT Labtech, United Kingdom
As Head of Corporate Development at SPT Labtech, Graeme leads M&A and partnering activities. Prior to joining SPT Labtech, Graeme served as Director of Healthcare Investment Banking at Piper Sandler (previously Piper Jaffray) where he worked for over 16 years and completed over 40 M&A and financing transactions in the healthcare and life sciences sector. Notable transactions that Graeme led in the tools space included the sale of the TapeStation automated electrophoresis system to Agilent, the sale of the ambr automated benchtop bioprocessing system to Sartoius Stedim, the sale of Genetix to Danaher and the sale of Novozymes' protein A business and cell culture ingredients to Repligen. Graeme obtained his PhD in Cancer Research from the University of Manchester in microarray analysis of stem cell differentiation.